Suppr超能文献

1995年至2005年期间日本国际传播的耐头孢菌素淋病奈瑟菌克隆的出现与演变

Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan.

作者信息

Shimuta Ken, Watanabe Yuko, Nakayama Shu-ichi, Morita-Ishihara Tomoko, Kuroki Toshiro, Unemo Magnus, Ohnishi Makoto

机构信息

National Institute of Infectious Diseases, Tokyo, Japan.

Kanagawa Prefectural Institute of Public Health, Kanagawa, Japan.

出版信息

BMC Infect Dis. 2015 Sep 17;15:378. doi: 10.1186/s12879-015-1110-x.

Abstract

BACKGROUND

Neisseria gonorrhoeae strains with resistance to extended-spectrum cephalosporins (ESCs), last options for first-line monotherapy of gonorrhoea, likely emerged and initially disseminated in Japan, followed by international transmission. In recent years, multi-locus sequence typing (MLST) ST1901 and N. gonorrhoeae multiantigen sequence typing (NG-MAST) ST1407 isolates with the mosaic penicillin-binding protein (PBP) 2 XXXIV have accounted for most ESC resistance globally. Our aim was to elucidate the initial emergence and transmission of ESC-resistant strains by detailed examination of N. gonorrhoeae isolates from 1995 to 2005 in Kanagawa, Japan.

METHODS

N. gonorrhoeae isolates were examined phenotypically (n = 690) and genetically (n = 372) by agar dilution method (cefixime, ceftriaxone and ciprofloxacin), penA gene sequencing, MLST and NG-MAST.

RESULTS

Already in 1995, one cefixime-resistant (CFM-R) isolate was found, which is the first CFM-R isolate described globally. After 1996, the prevalence of CFM-R and CFM-decreased susceptibility (CFM-DS) isolates significantly increased, with the peak resistance level in 2002 (57.1% CFM-R). In 1997-2002, the CFM-R MLST ST7363 strain type with the mosaic PBP 2 X was predominant among CFM-R/DS isolates. The first CFM-R/DS MLST ST1901 clone(s), which became the predominant CFM-R/DS strain type(s) already in 2003-2005, possessed the mosaic PBP 2 X, which was possibly originally transferred from the MLST ST7363 strains, and subsequently acquired the mosaic PBP 2 XXXIV. The first MLST ST1901 and NG-MAST ST1407 isolate was identified in Kanagawa already in 2003.

CONCLUSIONS

The two main internationally spread cefixime-resistant gonococcal clones, MLST ST7363 and ST1901 (NG-MAST ST1407 most frequent internationally) that also have shown their capacity to develop high-level ceftriaxone resistance (superbugs H041 and F89), likely emerged, evolved and started to disseminate in the metropolitan area, including Kanagawa, in Japan, which was followed by global transmission.

摘要

背景

对超广谱头孢菌素(ESCs)耐药的淋病奈瑟菌菌株,作为淋病一线单药治疗的最后选择,可能最早在日本出现并初步传播,随后在国际间传播。近年来,具有嵌合青霉素结合蛋白(PBP)2 XXXIV的多位点序列分型(MLST)ST1901和淋病奈瑟菌多抗原序列分型(NG-MAST)ST1407分离株在全球范围内导致了大多数对ESCs的耐药性。我们的目的是通过详细检测1995年至2005年日本神奈川县的淋病奈瑟菌分离株,来阐明对ESCs耐药菌株的最初出现和传播情况。

方法

采用琼脂稀释法(头孢克肟、头孢曲松和环丙沙星)、penA基因测序、MLST和NG-MAST对淋病奈瑟菌分离株进行表型(n = 690)和基因(n = 372)检测。

结果

早在1995年就发现了一株对头孢克肟耐药(CFM-R)的分离株,这是全球报道的首例CFM-R分离株。1996年后,CFM-R和CFM-敏感性降低(CFM-DS)分离株的流行率显著增加,2002年耐药水平达到峰值(57.1% CFM-R)。1997年至2002年,具有嵌合PBP 2 X的CFM-R MLST ST7363菌株类型在CFM-R/DS分离株中占主导地位。最早的CFM-R/DS MLST ST1901克隆株在2003年至2005年已成为主要的CFM-R/DS菌株类型,其具有嵌合PBP 2 X,可能最初是从MLST ST7363菌株转移而来,随后又获得了嵌合PBP 2 XXXIV。最早的MLST ST1901和NG-MAST ST1407分离株于2003年在神奈川县被鉴定出来。

结论

两种主要在国际上传播的对头孢克肟耐药的淋球菌克隆株,MLST ST7363和ST1901(国际上最常见的是NG-MAST ST1407),它们也表现出产生高水平头孢曲松耐药性的能力(超级细菌H041和F89),可能最早在日本包括神奈川县在内的大都市地区出现、进化并开始传播,随后在全球范围内传播。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8e0/4574456/c0c2ddc9c6f2/12879_2015_1110_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验